Your browser doesn't support javascript.
loading
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA.
Schattenberg, Jörn M; Pares, Albert; Kowdley, Kris V; Heneghan, Michael A; Caldwell, Stephen; Pratt, Daniel; Bonder, Alan; Hirschfield, Gideon M; Levy, Cynthia; Vierling, John; Jones, David; Tailleux, Anne; Staels, Bart; Megnien, Sophie; Hanf, Remy; Magrez, David; Birman, Pascal; Luketic, Velimir.
Afiliación
  • Schattenberg JM; Metabolic Liver Research Program, I. Department of Medicine, University Medical Centre Mainz, Germany. Electronic address: joern.schattenberg@unimedizin-mainz.de.
  • Pares A; Hospital Clinic, University of Barcelona, CIBERehd, IDIBAPS, Barcelona, Spain.
  • Kowdley KV; Liver Institute Northwest, Seattle, USA.
  • Heneghan MA; Institute of Liver Studies, Kings College Hospital, London, United Kingdom.
  • Caldwell S; University of Virginia, Charlottesville, Virginia, USA.
  • Pratt D; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Bonder A; Liver Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Hirschfield GM; Toronto Centre for Liver Disease, University Health Network and University of Toronto, Toronto, Canada.
  • Levy C; Division of Hepatology, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Vierling J; Baylor College of Medicine, Houston, Texas, USA.
  • Jones D; Newcastle University Medical School, Newcastle upon Tyne, United Kingdom.
  • Tailleux A; Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Staels B; Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Megnien S; GENFIT, 885 Avenue Eugene Avinee, 59120, Loos, France.
  • Hanf R; GENFIT, 885 Avenue Eugene Avinee, 59120, Loos, France.
  • Magrez D; GENFIT, 885 Avenue Eugene Avinee, 59120, Loos, France.
  • Birman P; GENFIT, 885 Avenue Eugene Avinee, 59120, Loos, France.
  • Luketic V; Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Health System, Richmond, Virginia, USA.
J Hepatol ; 74(6): 1344-1354, 2021 06.
Article en En | MEDLINE | ID: mdl-33484775
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_nao_transmissiveis Asunto principal: Propionatos / Ácido Ursodesoxicólico / Chalconas / PPAR alfa / PPAR delta / Cirrosis Hepática Biliar Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_nao_transmissiveis Asunto principal: Propionatos / Ácido Ursodesoxicólico / Chalconas / PPAR alfa / PPAR delta / Cirrosis Hepática Biliar Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article